These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16182312)

  • 1. Lower limb post-immobilization dystonia in Parkinson's disease.
    Singer C; Papapetropoulos S
    J Neurol Sci; 2005 Dec; 239(1):111-4. PubMed ID: 16182312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinsonian dystonia].
    Dowsey-Limousin P
    Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):928-31. PubMed ID: 14615683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
    Lim EC; Quek AM; Seet RC
    Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia.
    Truong L; Brooks D; Amaral F; Henderson JM; Halliday GM
    Mov Disord; 2009 Oct; 24(14):2128-35. PubMed ID: 19735086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postural reactions to soleus muscle vibration in Parkinson's disease: scaling deteriorates as disease progresses.
    Valkovic P; Krafczyk S; Bötzel K
    Neurosci Lett; 2006 Jun; 401(1-2):92-6. PubMed ID: 16574321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiological effects of pallidal deep brain stimulation in dystonia.
    Tisch S; Rothwell JC; Limousin P; Hariz MI; Corcos DM
    IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):166-72. PubMed ID: 17601185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptocormia: pathogenesis, classification, and response to therapy.
    Azher SN; Jankovic J
    Neurology; 2005 Aug; 65(3):355-9. PubMed ID: 16087897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset primary focal foot dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Jan; 12(1):57-60. PubMed ID: 16154790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pisa syndrome as a motor complication of Parkinson's disease.
    Kim JS; Park JW; Chung SW; Kim YI; Kim HT; Lee KS
    Parkinsonism Relat Disord; 2007 Mar; 13(2):126-8. PubMed ID: 16731022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N; Honigman S
    Mov Disord; 1997 Nov; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.